PD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Management of Young and Ageing Women with Afibrinogenemia and Hypofibrinogenemia | Hämostaseologie | 2025 | 34 | 186 | |||
| Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database | Blood advances | 2024 | 130 | 158 | |||
| Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen | Journal of thrombosis and haemostasis | 2024 | 96 | 0 | |||
| Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | 2024 | 83 | 0 | |||
| Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis | Haemophilia | 2024 | 52 | 0 | |||
| High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia | Haemophilia | 2023 | 68 | 0 | |||
| Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group | Haemophilia | 2023 | 98 | 0 | |||
| One Hundred Years of Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | 2022 | 327 | 0 | |||
| New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia | Thrombosis and haemostasis | 2022 | 159 | 0 | |||
| How I treat dysfibrinogenemia | Blood | 2021 | 349 | 1,224 | |||
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia | Blood | 2021 | 297 | 264 | |||
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | 2021 | 233 | 0 | |||
| Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion | Haemophilia | 2020 | 344 | 0 | |||
| Unravelling the knowledge, beliefs, behaviours and concerns of Persons with Haemophilia and their carriers in Senegal | Haemophilia | 2020 | 152 | 0 | |||
| Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management | Blood Reviews | 2020 | 269 | 429 | |||
| Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future | Haemophilia | 2019 | 313 | 0 | |||
| Impaired factor XIII activation in patients with congenital afibrinogenemia | Haematologica | 2019 | 361 | 141 | |||
| The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia | Haemophilia | 2019 | 377 | 0 | |||
| Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus | Rheumatology | 2018 | 399 | 1 | |||
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | 2018 | 596 | 890 | |||
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | 2018 | 436 | 243 | |||
| Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization | Haemophilia | 2017 | 442 | 1 | |||
| A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system | Journal of thrombosis and haemostasis | 2017 | 599 | 3 | |||
| Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation | Journal of thrombosis and haemostasis | 2017 | 621 | 254 | |||
| Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues | Haematologica | 2017 | 525 | 256 | |||
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | 2017 | 563 | 4 | |||
| Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | 2016 | 585 | 0 | |||
| Pregnancy | Trauma Induced Coagulopathy | 2016 | 438 | 2 | |||
| Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe | Haemophilia | 2016 | 402 | 0 | |||
| Clinical Features and Management of Congenital Fibrinogen Deficiencies | Seminars in thrombosis and hemostasis | 2016 | 607 | 5 | |||
| Can the phenotype of inherited fibrinogen disorders be predicted? | Haemophilia | 2016 | 655 | 2 | |||
| Preoperative hemostatic assessment: a new and simple bleeding questionnaire | Canadian journal of anaesthesia | 2016 | 517 | 0 | |||
| F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2 | Scientific reports | 2016 | 649 | 365 | |||
| Factor concentrates for rare congenital coagulation disorders: where are we now? | Expert opinion on orphan drugs | 2016 | 462 | 0 | |||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | 2016 | 537 | 0 | |||
| Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management | Nonmalignant Hematology Expert Clinical Review : Questions and Answers | 2016 | 509 | 0 | |||
| Natural history of patients with congenital dysfibrinogenemia | Blood | 2015 | 741 | 4 | |||
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis | Haemophilia | 2015 | 523 | 0 | |||
| Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial | Journal of thrombosis and haemostasis | 2015 | 500 | 0 | |||
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Journal of thrombosis and haemostasis | 2015 | 796 | 695 | |||
| Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature | Haemophilia | 2015 | 597 | 5 | |||
| NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes | Journal of thrombosis and haemostasis | 2014 | 538 | 0 | |||
| Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies | Journal of thrombosis and haemostasis | 2014 | 618 | 0 | |||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | 2014 | 662 | 3 | |||
| Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood | Thrombosis research | 2014 | 621 | 2 | |||
| Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies | Journal of thrombosis and haemostasis | 2014 | 637 | 5 | |||
| FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations | Thrombosis research | 2014 | 703 | 9 | |||
| Predicting deep venous thrombosis in pregnancy : external validation of the LEFT clinical prediction rule | Haematologica | 2013 | 66 | 304 | |||
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | 2013 | 649 | 0 | |||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | 2013 | 413 | 0 | |||
| Déficits rares de la coagulation et gestes invasifs | Annales françaises d'anesthésie et de réanimation | 2013 | 2 | 0 | |||
| Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery | Blood coagulation & fibrinolysis | 2013 | 517 | 0 | |||
| Receptors involved in cell activation by antiphospholipid antibodies | Thrombosis research | 2013 | 673 | 811 | |||
| Could Factor XIII be a solution for the management of surgical bleeding? | Management and Severe Bleeding | 2013 | 382 | 0 | |||
| TLR2 ligands induce NF-κB activation from endosomal compartments of human monocytes | PloS one | 2013 | 546 | 464 | |||
| Congenital fibrinogen disorders: an update | Seminars in thrombosis and hemostasis | 2013 | 751 | 0 | |||
| Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand? | Polskie Archiwum Medycyny Wewnętrznej | 2013 | 594 | 2 | |||
| Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications | Clinical & developmental immunology | 2013 | 673 | 2 | |||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | 2012 | 738 | 102 | |||
| Thrombophilie : quel bilan en 2012? | La Revue de médecine interne | 2012 | 506 | 0 | |||
| Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex | Journal of internal medicine | 2012 | 753 | 3 | |||
| Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency | Blood coagulation & fibrinolysis | 2012 | 590 | 0 | |||
| Inflammatory and prothrombotic states in obese children of European descent | Obesity | 2012 | 546 | 0 | |||
| Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia | Blood coagulation & fibrinolysis | 2012 | 621 | 0 | |||
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | 2011 | 654 | 0 | |||
| Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies | Blood | 2011 | 588 | 0 | |||
| A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family | Blood coagulation & fibrinolysis | 2011 | 670 | 1 | |||
| Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients | Blood coagulation & fibrinolysis | 2010 | 636 | 0 | |||
| Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency | Thrombosis and haemostasis | 2010 | 616 | 0 | |||
| Fibrinogen and the risk of thrombosis | Seminars in thrombosis and hemostasis | 2010 | 595 | 2 | |||
| Stenting carotidien: place de l'evidence-based medicine! | Revue médicale suisse | 2010 | 510 | 0 | |||
| Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome | Journal of thrombosis and haemostasis | 2010 | 607 | 0 | |||
| Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A' | Thrombosis and haemostasis | 2010 | 687 | 351 | |||
| Hémostase. Le point sur les nouveaux antithrombotiques | Revue médicale suisse | 2010 | 544 | 0 | |||
| The role of prophylaxis in bleeding disorders | Haemophilia | 2010 | 526 | 0 | |||
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | 2010 | 522 | 0 | |||
| Introduction de l'acénocoumarol à l'aide d'un algorithme de prescription | Revue médicale suisse | 2010 | 629 | 0 | |||
| Syndrome des anticorps antiphospholipides: beaucoup de nouveautés | Revue médicale suisse | 2010 | 543 | 0 | |||
| Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery | Thrombosis and haemostasis | 2010 | 650 | 0 | |||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | 2010 | 608 | 0 | |||
| The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study | Journal of thrombosis and haemostasis | 2009 | 583 | 0 | |||
| European curriculum for thrombosis and haemostasis | Haemophilia | 2009 | 491 | 0 | |||
| Diagnosis of mild bleeding disorders | Schweizerische medizinische Wochenschrift | 2009 | 643 | 1,183 | |||
| Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function | Thrombosis and haemostasis | 2009 | 673 | 1 | |||
| Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations | Thrombosis and haemostasis | 2009 | 552 | 0 | |||
| Evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism | Journal of thrombosis and haemostasis | 2009 | 541 | 0 | |||
| Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations | Haemophilia | 2009 | 515 | 0 | |||
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | 2009 | 564 | 0 | |||
| Anticoagulants in portal vein thrombosis: don't be so shy! | Blood | 2009 | 504 | 0 | |||
| Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation | Blood coagulation & fibrinolysis | 2009 | 567 | 0 | |||
| A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream | Blood coagulation & fibrinolysis | 2009 | 637 | 4 | |||
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | 2009 | 526 | 0 | |||
| Congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | 2009 | 637 | 0 | |||
| Assessing aspirin responsiveness using the Verify Now Aspirin assay | Thrombosis research | 2008 | 648 | 0 | |||
| Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides | Molecular immunology | 2008 | 662 | 0 | |||
| Treatment of congenital fibrinogen disorders | Expert opinion on biological therapy | 2008 | 552 | 0 | |||
| Chapter 12 Blood coagulation and fibrinolysis: mechanisms of thrombosis | Handbook of clinical neurology | 2008 | 549 | 0 | |||
| Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency | Blood | 2008 | 667 | 0 | |||
| A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism | Thrombosis and haemostasis | 2008 | 711 | 0 | |||
| Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream? | Seminars in thrombosis and hemostasis | 2008 | 603 | 0 | |||
| Invitation to a debate on the serological criteria that define the antiphospholipid syndrome | Journal of thrombosis and haemostasis | 2008 | 586 | 0 | |||
| Molecular analysis of F8 in Lebanese haemophilia A patients: novel mutations and phenotype-genotype correlation | Haemophilia | 2008 | 590 | 0 | |||
| A survey of adherence to haemophilia therapy in six European countries: results and recommendations | Haemophilia | 2008 | 635 | 0 | |||
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2008 | 664 | 0 | |||
| Preventing and treating bleeding complications: new insights into therapeutic options | Thrombosis research | 2008 | 532 | 0 | |||
| D-Dimer for venous thromboembolism diagnosis: 20 years later | Journal of thrombosis and haemostasis | 2008 | 638 | 0 | |||
| Mécanismes d'activation cellulaire par les anticorps antiphospholipides | Hématologie | 2008 | 614 | 0 | |||
| Rare bleeding disorders | Haemophilia | 2008 | 565 | 0 | |||
| Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome | Haematologica | 2008 | 654 | 484 | |||
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | 2008 | 539 | 1 | |||
| A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis | Blood coagulation & fibrinolysis | 2008 | 570 | 0 | |||
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | 2008 | 610 | 0 | |||
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | 2007 | 620 | 252 | |||
| Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique | Revue médicale suisse | 2007 | 412 | 0 | |||
| Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations | Human mutation | 2007 | 616 | 1 | |||
| Extensive thromboembolic event as initial presentation of monoclonal gammopathy of undetermined significance | Thrombosis and haemostasis | 2006 | 50 | 0 | |||
| Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient | Thrombosis and haemostasis | 2006 | 666 | 0 | |||
| Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency | Haematologica | 2005 | 493 | 0 | |||
| Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation | Journal of thrombosis and haemostasis | 2005 | 486 | 0 | |||
| Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion | Journal of medical genetics | 2005 | 507 | 1 | |||
| Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies | Thrombosis and haemostasis | 2005 | 718 | 451 | |||
| Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia | Human molecular genetics | 2005 | 672 | 4 | |||
| Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain | Blood coagulation & fibrinolysis | 2004 | 541 | 0 | |||
| Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells | Blood | 2004 | 659 | 0 | |||
| Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cutoff Value in Outpatients With Suspected Pulmonary Embolism | Archives of internal medicine | 2004 | 23 | 0 | |||
| Potential role of D‐dimer to rule in pulmonary embolism : a rebuttal | Journal of thrombosis and haemostasis | 2004 | 70 | 169 | |||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | 2004 | 544 | 0 | |||
| Purpura fulminans in a child as a complication of chickenpox infection | Dermatology | 2004 | 541 | 0 | |||
| Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion | Blood | 2003 | 592 | 0 | |||
| Are patients with paroxysmal nocturnal hemoglobinuria at risk for heparin-induced thrombocytopenia ? | Journal of thrombosis and haemostasis | 2003 | 87 | 145 | |||
| Rofecoxib interaction with oral anticoagulant acenocoumarol | European journal of clinical pharmacology | 2003 | 481 | 269 | |||
| Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation | The European respiratory journal | 2002 | 644 | 789 | |||
| Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes | Human genetics | 2001 | 621 | 0 | |||
| Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T | Blood | 2001 | 601 | 0 | |||
| Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells | Thrombosis and haemostasis | 2001 | 106 | 0 | |||
| Should the D-dimer Cut-off Value Be Increased in Elderly Patients Suspected of Pulmonary Embolism ? | Thrombosis and haemostasis | 2001 | 32 | 0 | |||
| Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty | Blood coagulation & fibrinolysis | 2000 | 508 | 0 | |||
| Interaction of Anti-Phospholipid Antibodies With Late Endosomes of Human Endothelial Cells | Arteriosclerosis, thrombosis, and vascular biology | 2000 | 491 | 1 | |||
| Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia | Blood | 2000 | 592 | 1 | |||
| Massive thromboembolism due to transcatheter ASD closure with ASDOS device | The Journal of invasive cardiology | 1999 | 451 | 0 | |||
| Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors | Haemophilia | 1999 | 608 | 0 | |||
| Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty | Blood coagulation & fibrinolysis | 1998 | 552 | 0 | |||
| Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up | Age and ageing | 1997 | 577 | 141 | |||
| Factor VIII gene inversions in severe hemophilia A: results of an international consortium study | Blood | 1995 | 581 | 3 | |||
| Molecular etiology of factor VIII deficiency in hemophilia A | Advances in experimental medicine and biology | 1995 | 566 | 0 | |||
| Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems | The international journal of artificial organs | 1990 | 669 | 0 |
